Corrections Correction in the article by the SEC Working Group and Expert Reviewers for the 2019 ESC/EAS guidelines for the management of dyslipidaemias, and SEC Guidelines Committe “Comments on the 2019 ESC/EAS guidelines for the management of dyslipidemias”, Rev Esp Cardiol. 2020;73:348–353

In the article “Comments on the 2019 ESC/EAS guidelines for the management of dyslipidemias”, an error was detected in table 2. In line 4, High, column 5, Relative reduction in LDL-C, the value ≥ 50% was missing.

Table 2.

Cardiovascular risk stratification and therapeutic goals for diabetic patients

Risk category	Characteristics			Therapeutic goal
	TOL	Additional CVRFs	DM timeline	Relative LDL-C reduction	Absolute value (mg/dL)
Very high	Yes	≥ 3	Duration of DM1 > 20 y	≥ 50%	< 55
High	No	1	Duration > 10 y	≥ 50%	< 70
Moderate	No	No	Young diabetics:		< 100
			DM1, < 35 y
			DM2, age < 50 y and duration < 10 y
Low	[0,2-6]	No diabetics are considered to be low risk

CVRF, cardiovascular risk factors; DM1, type 1 diabetes mellitus; DM2, type 2 diabetes mellitus; LDL-C, low-density lipoprotein cholesterol; TOL, target organ lesion.

The correct table is:

This correction has been made to the electronic version of the article on 12th October 2020.